Home › B-Cell Lymphoma › Virginia › Richmond
B-Cell Lymphoma clinical trials in Richmond, VA
5 studies for B-Cell Lymphoma are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Virginia Commonwealth University-Massey Cancer Center, Richmond
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- Massey Cancer Center, Richmond
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecruitingPhase 3
- Vcu Massey Cancer Center, Richmond
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Virginia Commonwealth University-Massey Cancer Center, Richmond
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecruitingPhase 3
- Virginia Cancer Institute, Richmond
B-Cell Lymphoma trials in other cities
- New York City, NY17 studies
- Houston, TX16 studies
- Chicago, IL13 studies
- Nashville, TN12 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Milwaukee, WI10 studies
- Boston, MA10 studies
- Baldwin Park, CA9 studies
- Cleveland, OH8 studies
- Salt Lake City, UT8 studies
- Seattle, WA8 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.